Background: The Developmental Eye Movement Test (DEM) is a widely used visual skill test, especially in the context of a vision therapy evaluation. It is intended to diagnose oculomotor dysfunction (OMD) and can also identify deficient rapid automatized naming. As such, its reliability and associated symptomatology are important.

Methods: The DEM test-retest reliability was investigated within two populations: a group of 53 office patients who were participating in vision therapy evaluation in a private optometry practice, and a smaller group of 13 subjects at their school. One to four weeks separated the test and retest for both groups. We also studied the relationship between results on a questionnaire of symptoms associated with OMD and DEM test performance in these two populations.

Results: The first administration of the DEM significantly correlated with the second for all four of its scores for both groups. The office group had higher intra-class correlation coefficients than the school group. There was good agreement between test and re-test in terms of pass-fail classification for the office group. Symptomatic subjects performed poorer than asymptomatic subjects on the DEM. Failing the DEM Ratio, the score used to diagnose OMD, identified 90% of the subjects who were symptomatic.

Conclusions: The DEM has good intra-subject test-retest reliability for all four of its scores when it is administered in an office setting to patients participating in a vision therapy evaluation. It also has good consistency in classifying patients as pass or fail. Performance on the DEM relates to certain symptoms that are associated with OMD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.optm.2005.05.006DOI Listing

Publication Analysis

Top Keywords

vision therapy
12
therapy evaluation
12
developmental eye
8
eye movement
8
movement test
8
dem
8
test-retest reliability
8
patients participating
8
participating vision
8
symptoms associated
8

Similar Publications

A 21-year-old woman presented with progressive proptosis of the right eye with blurring of vision for the past 6 months. MRI showed an intra-orbital lesion that was T1 isointense, T2 hyperintense, and well enhancing on contrast. The patient underwent right frontal craniotomy, superior orbitotomy, and decompression of the lesion.

View Article and Find Full Text PDF

[New perspectives on facial asymmetries thanks to 3D vision].

Orthod Fr

January 2025

35C impasse des brasseries, 54700 Pont-à-Mousson, France

Introduction: Modern orthodontics is undergoing a revolution with the advent of 3D imaging, offering unprecedented perspectives for the evaluation and treatment of facial asymmetries. These asymmetries, whether mandibular, maxillary, or dental, require a deeper understanding of their causes and their aesthetic and functional impact. Additionally, associated functional imbalances must be addressed for comprehensive management.

View Article and Find Full Text PDF

The use of checkpoint inhibitors has shown significant clinical benefit in various cancer types but also carries a risk of immune-related adverse events (irAEs). As the use of checkpoint inhibitors continues to rise, so does the incidence of irAEs. Among these, neurological adverse events (neuro-irAEs) are particularly challenging to detect since they can manifest with a wide range of symptoms, often mimicking disease progression.

View Article and Find Full Text PDF

Acquired Dyschromatopsia and Its Link to Drug Toxicity.

Cureus

December 2024

Optometric - Glaucoma, Leicester Royal Infirmary, Leicester, GBR.

Colour vision defects (CVDs) can be both congenital and acquired, with acquired dyschromatopsia often associated with medication toxicity. This review explores various standardised colour vision tests used to detect these defects, including the Ishihara plate test, Farnsworth-Munsell 100 hue test, and anomaloscopes. These methods are evaluated for their effectiveness in diagnosing CVDs, particularly in acquired conditions.

View Article and Find Full Text PDF

Purpose: We aimed to build a machine learning-based model to predict radiation-induced optic neuropathy in patients who had treated head and neck cancers with radiotherapy.

Materials And Methods: To measure radiation-induced optic neuropathy, the visual evoked potential values were obtained in both case and control groups and compared. Radiomics features were extracted from the area segmented which included the right and left optic nerves and chiasm.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!